Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Deprez

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Biochemistry|June 5, 2002
DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the novioseDaniel Lafitte, Valérie Lamour, Philippe O Tsvetkov, et al.
Endoscopy International Open|October 20, 2022
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease: an observational prospective multicenter studyMariana Figueiredo Ferreira, Rodrigo Garces-Duran, Pierre Eisendrath, et al.
Journal of Cardiothoracic Surgery|December 1, 2009
Gastro-tracheal fistula--unusual and life threatening complication after esophagectomy for cancer: a case reportJane E Nardella, Dirk Van Raemdonck, Hubert Piessevaux, et al.
Journal of Medicinal Chemistry|November 14, 2003
Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitorsGudrun Lange, Dominique Lesuisse, Pierre Deprez, et al.
Journal of Medicinal Chemistry|June 28, 2002
Principles governing the binding of a class of non-peptidic inhibitors to the SH2 domain of src studied by X-ray analysisGudrun Lange, Dominique Lesuisse, Pierre Deprez, et al.
Journal of Molecular Endocrinology|December 24, 2008
No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditionsPetrine Wellendorph, Lars Dan Johansen, Anders A Jensen, et al.
Biochemical and Biophysical Research Communications|October 22, 2002
High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo systemEliane Mandine, Véronique Jean-Baptiste, Béatrice Vayssière, et al.
Gastrointestinal Endoscopy|April 1, 2015
Endoscopic features of lymphoproliferative diseasesGeorgios Mavrogenis, Alessandra Camboni, Marie-Armelle Denis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2012
Efficacy of endoscopic closure of acute perforations of the gastrointestinal tractRogier P Voermans, Olivier Le Moine, Daniel von Renteln, et al.
Journal of Medicinal Chemistry|May 31, 2002
SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2Dominique Lesuisse, Gudrun Lange, Pierre Deprez, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Biochemistry|June 5, 2002
DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the novioseDaniel Lafitte, Valérie Lamour, Philippe O Tsvetkov, et al.
Endoscopy International Open|October 20, 2022
EUS-guided radiofrequency ablation of pancreatic/peripancreatic tumors and oligometastatic disease: an observational prospective multicenter studyMariana Figueiredo Ferreira, Rodrigo Garces-Duran, Pierre Eisendrath, et al.
Journal of Cardiothoracic Surgery|December 1, 2009
Gastro-tracheal fistula--unusual and life threatening complication after esophagectomy for cancer: a case reportJane E Nardella, Dirk Van Raemdonck, Hubert Piessevaux, et al.
Journal of Medicinal Chemistry|November 14, 2003
Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitorsGudrun Lange, Dominique Lesuisse, Pierre Deprez, et al.
Journal of Medicinal Chemistry|June 28, 2002
Principles governing the binding of a class of non-peptidic inhibitors to the SH2 domain of src studied by X-ray analysisGudrun Lange, Dominique Lesuisse, Pierre Deprez, et al.
Journal of Molecular Endocrinology|December 24, 2008
No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditionsPetrine Wellendorph, Lars Dan Johansen, Anders A Jensen, et al.
Biochemical and Biophysical Research Communications|October 22, 2002
High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo systemEliane Mandine, Véronique Jean-Baptiste, Béatrice Vayssière, et al.
Gastrointestinal Endoscopy|April 1, 2015
Endoscopic features of lymphoproliferative diseasesGeorgios Mavrogenis, Alessandra Camboni, Marie-Armelle Denis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 25, 2012
Efficacy of endoscopic closure of acute perforations of the gastrointestinal tractRogier P Voermans, Olivier Le Moine, Daniel von Renteln, et al.
Journal of Medicinal Chemistry|May 31, 2002
SAR and X-ray. A new approach combining fragment-based screening and rational drug design: application to the discovery of nanomolar inhibitors of Src SH2Dominique Lesuisse, Gudrun Lange, Pierre Deprez, et al.
Pageof 7